Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase 1 Study of YZJ-4729 Tartrate Injection
NCT06681493Phase 1Completed
- Sponsor
- Shanghai Haiyan Pharmaceutical Technology Co., Ltd.
- Start
- Oct 2022
- Primary completion
- Apr 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1 trial of YZJ-4729 in postoperative pain (2 arms), sponsored by Shanghai Haiyan Pharmaceutical Technology Co., Ltd. Primary endpoints: Incidence of adverse events and serious adverse events, Incidence of participants with clinical laboratory abnormalities and 13 more. Started Oct 2022; status: completed.
02
Drugs
YZJ-4729
03
Conditions
postoperative pain
Beyond the preview
Go deeper on NCT06681493.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06681493.